Moxifloxacin Hydrochloride 0.5% + Dexamethasone 0.1% 5 ml Eye Drops (Moxirut-D)
Moxifloxacin HCl 0.5% + Dexamethasone 0.1% — Antibiotic + Steroid
| Composition | Moxifloxacin HCl 0.5% + Dexamethasone 0.1% (5 ml Eye Drops) |
|---|---|
| Dosage Form | Eye Drops |
| Pack Type | Bottle |
| Pack Size | 5ml |
| MRP | ₹ 110 |
| Therapy | Ophthalmic — 4th-gen fluoroquinolone + corticosteroid |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Moxirut-D (moxifloxacin hydrochloride 0.5% + dexamethasone 0.1% 5 ml eye drops) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
About Moxirut-D Eye Drops
Moxirut-D Eye Drops combines Moxifloxacin HCl 0.5% with Dexamethasone 0.1% to address both bacterial infection and accompanying inflammation in one ophthalmic preparation.
Indicated for inflamed bacterial conjunctivitis, bacterial keratitis with marked inflammation and post-operative inflammation with infection-risk.
Camrut Healthcare manufactures Moxirut-D under WHO-GMP injectable conditions for PCD pharma franchise across India.
Moxirut-D का उपयोग (हिंदी में): आँख के संक्रमण की ड्रॉप। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Inflamed bacterial conjunctivitis
- Bacterial keratitis with prominent inflammation
- Post-operative ocular inflammation with infection risk
Mechanism of Action
Moxifloxacin is a 4th-generation fluoroquinolone that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, halting bacterial DNA replication. Its 8-methoxy substitution gives enhanced Gram-positive, atypical and anaerobic coverage with reduced resistance development. Dexamethasone is a potent corticosteroid that binds glucocorticoid receptors and suppresses local inflammation via lipocortin induction. The combination provides both antibacterial and anti-inflammatory action.
Dosage & Administration
['1 drop every 2–6 hours initially, reducing to 4 times daily', 'Use for maximum 1–2 weeks', 'Monitor IOP if used > 10 days']
Side Effects
['Stinging', 'Increased IOP (with prolonged use)', 'Cataract (with prolonged use)', 'Bitter taste']
Contraindications & Precautions
['Viral or fungal ocular infection', 'Active untreated TB', 'Steroid hypersensitivity', 'Children under 2 years']
Storage
Store below 25°C.
From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the ophthalmic products franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Moxirut-D Eye Drops is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
- Moxirut-LP Eye Drops — Moxifloxacin HCl 0.5% + Loteprednol Etabonate 0.5% (5 ml Eye Drops)
- Moxirut-DF Eye Drops — Moxifloxacin 0.5% w/v + Difluprednate 0.05% w/v
